Twenty-Three-Year Trends in the Use of Potentially Nephrotoxic Drugs in Denmark

References

• Naughton CA. Drug-induced nephrotoxicity. Am Fam Physician. 2008;78(6):743–750.
   PubMed Web of Science ®Google Scholar
• Rolland AL, Garnier AS, Meunier K, Drablier G, Briet M. Drug-Induced Acute Kidney Injury: a Study from the French Medical Administrative and the French National Pharmacovigilance Databases Using Capture-Recapture Method. J Clin Med. 2021;10(2):168. doi:10.3390/jcm10020168
   PubMed Web of Science ®Google Scholar
• Negi S, Koreeda D, Kobayashi S, et al. Acute kidney injury: epidemiology, outcomes, complications, and therapeutic strategies. Semin Dial. 2018;31(5):519–527. doi:10.1111/sdi.12705
   PubMed Web of Science ®Google Scholar
• Sawhney S, Fraser SD. Epidemiology of AKI: utilizing Large Databases to Determine the Burden of AKI. Adv Chronic Kidney Dis. 2017;24(4):194–204. doi:10.1053/j.ackd.2017.05.001
   PubMed Web of Science ®Google Scholar
• Hsu CY, McCulloch CE, Fan D, Ordoñez JD, Chertow GM, Go AS. Community-based incidence of acute renal failure. Kidney Int. 2007;72(2):208–212. doi:10.1038/sj.ki.5002297
   PubMed Web of Science ®Google Scholar
• Stack AG, Li X, Kaballo MA, et al. Temporal trends in acute kidney injury across health care settings in the Irish health system: a cohort study. Nephrol Dial Transplant. 2020;35(3):447–457. doi:10.1093/ndt/gfy226
   PubMed Web of Science ®Google Scholar
• Cockwell P, Fisher LA. The global burden of chronic kidney disease. Lancet. 2020;395(10225):662–664.
   PubMed Web of Science ®Google Scholar
• Schetz M, Dasta J, Goldstein S, Golper T. Drug-induced acute kidney injury. Curr Opin Crit Care. 2005;11(6):555–565. doi:10.1097/01.ccx.0000184300.68383.95
   PubMed Web of Science ®Google Scholar
• Oliveira JF, Silva CA, Barbieri CD, Oliveira GM, Zanetta DM, Burdmann EA. Prevalence and risk factors for aminoglycoside nephrotoxicity in intensive care units. Antimicrob Agents Chemother. 2009;53(7):2887–2891. doi:10.1128/AAC.01430-08
   PubMed Web of Science ®Google Scholar
• Ozkok A, Edelstein CL. Pathophysiology of cisplatin-induced acute kidney injury. Biomed Res Int. 2014;2014:967826. doi:10.1155/2014/967826
   PubMed Web of Science ®Google Scholar
• Naesens M, Kuypers DR, Sarwal M. Calcineurin inhibitor nephrotoxicity. Clin J Am Soc Nephrol. 2009;4(2):481–508. doi:10.2215/CJN.04800908
   PubMed Web of Science ®Google Scholar
• Rocha PN, Kobayashi CD. Incidence, Predictors, and Impact on Hospital Mortality of Amphotericin B Nephrotoxicity Defined Using Newer Acute Kidney Injury Diagnostic Criteria. Antimicrob Agents Chemother. 2015;59(8):4759–4769. doi:10.1128/AAC.00525-15
   PubMed Web of Science ®Google Scholar
• McCullough PA. Radiocontrast-induced acute kidney injury. Nephron Physiol. 2008;109(4):p61–72. doi:10.1159/000142938
   PubMedGoogle Scholar
• Vlachopanos G, Schizas D, Hasemaki N, Georgalis A. Pathophysiology of Contrast-Induced Acute Kidney Injury (CIAKI). Curr Pharm Des. 2019;25(44):4642–4647. doi:10.2174/1381612825666191210152944
   PubMed Web of Science ®Google Scholar
• Widemann BC, Adamson PC. Understanding and managing methotrexate nephrotoxicity. Oncologist. 2006;11(6):694–703. doi:10.1634/theoncologist.11-6-694
   PubMed Web of Science ®Google Scholar
• McCrae JC, Morrison EE, MacIntyre IM, Dear JW, Webb DJ. Long-term adverse effects of paracetamol - a review. Br J Clin Pharmacol. 2018;84(10):2218–2230. doi:10.1111/bcp.13656
   PubMed Web of Science ®Google Scholar
• Fored CM, Ejerblad E, Lindblad P, et al. Acetaminophen, aspirin, and chronic renal failure. N Engl J Med. 2001;345(25):1801–1808. doi:10.1056/NEJMoa010323
   PubMed Web of Science ®Google Scholar
• Perneger TV, Whelton PK, Klag MJ. Risk of kidney failure associated with the use of Acetaminophen, aspirin, and nonsteroidal antiinflammatory drugs. N Engl J Med. 1994;331(25):1675–1679. doi:10.1056/NEJM199412223312502
   PubMed Web of Science ®Google Scholar
• Markowitz GS, Perazella MA. Drug-induced renal failure: a focus on tubulointerstitial disease. Clin Chim Acta. 2005;351(1–2):31–47. doi:10.1016/j.cccn.2004.09.005
   PubMed Web of Science ®Google Scholar
• Adelborg K, Grove EL, Sundbøll J, Laursen M, Schmidt M. Sixteen-year nationwide trends in antithrombotic drug use in Denmark and its correlation with landmark studies. Heart. 2016;102(23):1883–1889. doi:10.1136/heartjnl-2016-309402
   PubMed Web of Science ®Google Scholar
• Sundbøll J, Adelborg K, Mansfield KE, Tomlinson LA, Seventeen-Year Nationwide SM. Trends in Antihypertensive Drug Use in Denmark. Am J Cardiol. 2017;120(12):2193–2200. doi:10.1016/j.amjcard.2017.08.042
   PubMed Web of Science ®Google Scholar
• Mortensen MB, Falk E, Schmidt M. Twenty-Year Nationwide Trends in Statin Utilization and Expenditure in Denmark. Circ Cardiovasc Qual Outcomes. 2017;10(7). doi:10.1161/CIRCOUTCOMES.117.003811
   PubMed Web of Science ®Google Scholar
• Bang C, Mortensen MB, Lauridsen KG, Bruun JM. Trends in antidiabetic drug utilization and expenditure in Denmark: a 22-year nationwide study. Diabetes Obes Metab. 2020;22(2):167–172. doi:10.1111/dom.13877
   PubMed Web of Science ®Google Scholar
• Poulsen CB, Damkjær M, Løfgren B, Schmidt M. Trends in Antiarrhythmic Drug Use in Denmark Over 19 Years. Am J Cardiol. 2020;125(4):562–569. doi:10.1016/j.amjcard.2019.11.009
   PubMed Web of Science ®Google Scholar
• Nissen SK, Pottegård A, Ryg J. Trends of Opioid Utilisation in Denmark: a Nationwide Study. Drugs Real World Outcomes. 2019;6(4):155–164. doi:10.1007/s40801-019-00163-w
   PubMedGoogle Scholar
• Wastesson JW, Martikainen JE, Zoëga H, Schmidt M, Karlstad Ø, Pottegård A. Trends in Use of Paracetamol in the Nordic Countries. Basic Clin Pharmacol Toxicol. 2018;123(3):301–307. doi:10.1111/bcpt.13003
   PubMed Web of Science ®Google Scholar
• Bosi A, Xu Y, Gasparini A, et al. Use of nephrotoxic medications in adults with chronic kidney disease in Swedish and US routine care. Clin Kidney J. 2022;15(3):442–451. doi:10.1093/ckj/sfab210
   PubMed Web of Science ®Google Scholar
• Ehrmann S, Helms J, Joret A, et al. Nephrotoxic drug burden among 1001 critically ill patients: impact on acute kidney injury. Ann Intensive Care. 2019;9(1):106. doi:10.1186/s13613-019-0580-1
   PubMed Web of Science ®Google Scholar
• Statistics Denmark. Available from: https://www.dst.dk/en. Accessed January 25, 2023.
   Google Scholar
• Medical Statistics (MedStat). The Danish Health Data Authority. Available from: https://www.medstat.dk/en. Accessed January 25, 2023.
   Google Scholar
• Kildemoes HW, Sørensen HT, Hallas J. The Danish National Prescription Registry. Scand J Public Health. 2011;39(7 Suppl):38–41. doi:10.1177/1403494810394717
   PubMed Web of Science ®Google Scholar
• Schmidt M, Hallas J, Laursen M, Friis S. Data Resource Profile: Danish online drug use statistics (MEDSTAT). Int J Epidemiol. 2016;45(5):1401–1402g. doi:10.1093/ije/dyw116
   PubMed Web of Science ®Google Scholar
• ”Data basis and description”, Medical Statistics (MedStat), The Danish Health Data Authority. Available from: https://medstat.dk/en/view/datagrundlag_og_beskrivelse. Accessed January 25, 2023.
   Google Scholar
• Anderson JW, Nicolosi RJ, Borzelleca JF. Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy. Food Chem Toxicol. 2005;43(2):187–201. doi:10.1016/j.fct.2004.11.006
   PubMed Web of Science ®Google Scholar
• Omori DM, Potyk RP, Kroenke K. The adverse effects of hospitalization on drug regimens. Arch Intern Med. 1991;151(8):1562–1564. doi:10.1001/archinte.1991.00400080064011
   PubMedGoogle Scholar
• DiMatteo MR. Variations in patients’ adherence to medical recommendations: a quantitative review of 50 years of research. Med Care. 2004;42(3):200–209. doi:10.1097/01.mlr.0000114908.90348.f9
   PubMed Web of Science ®Google Scholar
• Molloy GJ, Messerli-Bürgy N, Hutton G, Wikman A, Perkins-Porras L, Steptoe A. Intentional and unintentional non-adherence to medications following an acute coronary syndrome: a longitudinal study. J Psychosom Res. 2014;76(5):430–432. doi:10.1016/j.jpsychores.2014.02.007
   PubMed Web of Science ®Google Scholar
• Voils CI, King HA, Neelon B, et al. Characterizing weekly self-reported antihypertensive medication nonadherence across repeated occasions. Patient Prefer Adherence. 2014;8:643–650. doi:10.2147/PPA.S60715
   PubMed Web of Science ®Google Scholar
• Oksuzyan A, Höhn A, Krabbe Pedersen J, Rau R, Lindahl-Jacobsen R, Christensen K. Preparing for the future: the changing demographic composition of hospital patients in Denmark between 2013 and 2050. PLoS One. 2020;15(9):e0238912. doi:10.1371/journal.pone.0238912
   PubMed Web of Science ®Google Scholar
• Beard JR, Bloom DE. Towards a comprehensive public health response to population ageing. Lancet. 2015;385(9968):658–661. doi:10.1016/S0140-6736(14)61461-6
   PubMed Web of Science ®Google Scholar
• Gray MP, Barreto EF, Schreier DJ, et al. Consensus Obtained for the Nephrotoxic Potential of 167 Drugs in Adult Critically Ill Patients Using a Modified Delphi Method. Drug Saf. 2022;45(4):389–398. doi:10.1007/s40264-022-01173-4
   PubMed Web of Science ®Google Scholar
• ”Application for DDD alterations”, WHO Collaborating Centre for Drug Statistics Methodology. Available from: https://www.whocc.no/ddd/application_for_ddd_alterations/. Accessed January 25, 2023.
   Google Scholar
• Lewington S, Clarke R, Qizilbash N, Peto R, Collins R. Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies. Lancet. 2002;360(9349):1903–1913.
   PubMed Web of Science ®Google Scholar
• Neal B, MacMahon S, Chapman N. Effects of ACE inhibitors, calcium antagonists, and other blood-pressure-lowering drugs: results of prospectively designed overviews of randomised trials. Blood Pressure Lowering Treatment Trialists’ Collaboration. Lancet. 2000;356(9246):1955–1964.
   PubMed Web of Science ®Google Scholar
• Taylor AA, Siragy H, Nesbitt S. Angiotensin receptor blockers: pharmacology, efficacy, and safety. J Clin Hypertens. 2011;13(9):677–686. doi:10.1111/j.1751-7176.2011.00518.x
   PubMed Web of Science ®Google Scholar
• Siew ED, Davenport A. The growth of acute kidney injury: a rising tide or just closer attention to detail? Kidney Int. 2015;87(1):46–61. doi:10.1038/ki.2014.293
   PubMed Web of Science ®Google Scholar
• Lapi F, Azoulay L, Yin H, Nessim SJ, Suissa S. Concurrent use of diuretics, angiotensin converting enzyme inhibitors, and angiotensin receptor blockers with non-steroidal anti-inflammatory drugs and risk of acute kidney injury: nested case-control study. BMJ. 2013;346(jan08 12):e8525. doi:10.1136/bmj.e8525
   PubMedGoogle Scholar
• Jüni P, Nartey L, Reichenbach S, Sterchi R, Dieppe PA, Egger M. Risk of cardiovascular events and rofecoxib: cumulative meta-analysis. Lancet. 2004;364(9450):2021–2029. doi:10.1016/S0140-6736(04)17514-4
   PubMed Web of Science ®Google Scholar
• Lanas A, García-Rodríguez LA, Arroyo MT, et al. Risk of upper gastrointestinal ulcer bleeding associated with selective cyclo-oxygenase-2 inhibitors, traditional non-aspirin non-steroidal anti-inflammatory drugs, aspirin and combinations. Gut. 2006;55(12):1731–1738. doi:10.1136/gut.2005.080754
   PubMed Web of Science ®Google Scholar
• Schmidt M, Hallas J, Friis S. Potential of prescription registries to capture individual-level use of aspirin and other nonsteroidal anti-inflammatory drugs in Denmark: trends in utilization 1999-2012. Clin Epidemiol. 2014;6:155–168. doi:10.2147/CLEP.S59156
   PubMed Web of Science ®Google Scholar
• Ungprasert P, Cheungpasitporn W, Crowson CS, Matteson EL. Individual non-steroidal anti-inflammatory drugs and risk of acute kidney injury: a systematic review and meta-analysis of observational studies. Eur J Intern Med. 2015;26(4):285–291. doi:10.1016/j.ejim.2015.03.008
   PubMed Web of Science ®Google Scholar
• Morthorst BR, Erlangsen A, Chaine M, et al. Restriction of non-opioid analgesics sold over-The-counter in Denmark: a national study of impact on poisonings. J Affect Disord. 2020;268:61–68. doi:10.1016/j.jad.2020.02.043
   PubMed Web of Science ®Google Scholar
• Piepoli MF, Hoes AW, Agewall S, et al. 2016 European Guidelines on cardiovascular disease prevention in clinical practice: the Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts): developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR). Eur J Prev Cardiol. 2016;23(11):Np1–np96. doi:10.1177/2047487316653709
   PubMed Web of Science ®Google Scholar